Wordt geladen...
Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanorings
Type I interferon inducers may potentially be engineered to function as antiviral and anticancer agents, or alternatively, vaccine adjuvants, all of which may have clinical applications. We recently described a simple strategy to convert a Toll-like receptor 9 (TLR9) agonist devoid of interferon α (...
Bewaard in:
Gepubliceerd in: | Oncoimmunology |
---|---|
Hoofdauteurs: | , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Taylor & Francis
2014
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292235/ https://ncbi.nlm.nih.gov/pubmed/25610738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.950166 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|